Vicagrel

维卡格雷

Report date: 2025/12/25 15:59:47
NME

Base Information

Drug NameVicagrel
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 antagonistsPlatelet aggregation inhibitors
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThromboembolismPeripheral Arterial DiseaseAtherosclerosis +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Vcare Pharmatech Co LtdChina Pharmaceutical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Vcare Pharmatech Co LtdChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsThromboembolismPeripheral Arterial DiseaseMyocardial Infarction +[7] 
Inactive IndicationsAtherosclerosisVascular DiseasesCoronary Artery Disease +[5] 

Other Information

ATC CodeN/A
Related LinksDrugBank